A Mab A Case Study In Bioprocess Development __exclusive__ Today
Protein A capacity remains stable at 40 g/L resin. Elution at pH 3.5 yields 95% purity with <0.1% aggregates. However, the low-pH elution creates a new problem: inactivation of a small fraction of Mab-X, reducing potency by 10%.
to find the "Design Space"—the range where these factors can vary without affecting the product. PharmTech.com 3. Downstream Process Development (Purification) A Mab A Case Study In Bioprocess Development